EVO.NASDAQEvotec SE

SCHEDULE: Triton Funds Convert Evotec SE Swap to Direct Equity

Sentiment:

Beneficial Ownership Update (Schedule 13D/A)


Triton-affiliated entities, including Excalibur LuxCo SARL, have converted a swap agreement into direct ownership of 3.55 million Evotec SE ordinary shares, maintaining a 9.99% stake.

Summary

  • Excalibur LuxCo SARL, along with other Triton Fund 6 entities, beneficially owns 17,730,913 Ordinary Shares of Evotec SE.
  • This represents 9.99% of Evotec SE's Ordinary Shares outstanding, calculated based on 177,561,699 shares as of June 30, 2025.
  • On October 27, 2025, LuxCo exercised its right under a Swap Agreement to acquire 3,551,067 Subject Shares at a reference price of Euro 7.46 per share.
  • Following this exercise, the aggregate beneficial ownership and percentage of the class held by the reporting persons remain unchanged.
  • The reporting persons now hold all 17,730,913 reported securities as direct voting Ordinary Shares, converting from a previous derivative-based holding.

Sentiment

Score: 5

Explanation: The filing is a factual disclosure of a change in the form of beneficial ownership, maintaining a neutral sentiment for the issuer. It reflects a procedural update rather than a performance indicator.

Positives

  • The reporting persons have solidified their commitment to Evotec SE by converting derivative holdings into direct voting Ordinary Shares.
  • The exercise of the swap agreement at a reference price of Euro 7.46 per share indicates a specific valuation point for a portion of the holding.

Negatives

  • No explicit negative points for Evotec SE are detailed in this ownership disclosure.

Future Outlook

This filing does not contain forward-looking statements or guidance from Evotec SE.

Industry Context

This filing primarily concerns a change in the form of beneficial ownership by a significant investor group in Evotec SE, rather than broader industry trends. It reflects a specific investment strategy by the Triton Funds regarding their stake in the biotechnology sector.

Related Party Transactions

  • Excalibur LuxCo SARL exercised its right to acquire 3,551,067 shares under a Swap Agreement, which represents a transaction between the reporting person and a counterparty (not explicitly named as a related party to Evotec SE in this filing, but part of the reporting group's investment strategy).

Stakeholder Impact

  • Shareholders: The change from derivative to direct voting shares clarifies the voting power and long-term commitment of a significant shareholder group, potentially increasing transparency regarding their influence.
  • Management: Increased direct equity ownership by a major investor could imply a more direct engagement with company strategy and governance.

Key Dates

DateDescription
2024-11-08Original Schedule 13D filing date
2025-06-30Date of outstanding shares calculation (177,561,699 Ordinary Shares) as per Issuer's Form 6-K
2025-08-13Date of Issuer's Current Report on Form 6-K disclosing outstanding shares
2025-10-27Date Excalibur LuxCo SARL exercised the right to acquire 3,551,067 Subject Shares under the Swap Agreement
2025-10-29Date of signing for the Amendment No. 1 to Schedule 13D

Keywords

Evotec SE, Schedule 13D, Beneficial Ownership, Triton Fund, Excalibur LuxCo SARL, Swap Agreement, Equity Conversion, Ordinary Shares

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.